1) A novel skin penetration enhancer: Evaluation by membrane diffusion and confocal microscopy. Saunders J C J, Davis H J, Coetzee L , Botha S, Kruger A E, Grobler A*. MeyerZall Laboratories, *Medical Research Council. J Pharm Pharmaceut Sci 2(3):99-107, 1999.

2) In vitro comparative studies demonstrating trans dermal delivery vehicle properties utilising laser microscopy and membrane diffusion. Saunders J C J, Grobler A*, Davis H J, Kruger A E *Medical Research Council, others MeyerZall Laboratories. Poster presented at Dermatology Congress, Wilderness, South Africa 1999.

3) Double-blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis. Journal of Dermatological Treatment (2003) 14, 1-9. Goodfield M, Kownacki S and Berth-Jones J.

4) A new coal tar extract [Exorex Lotion] in the treatment of psoriasis and atopic dermatitis; Experience in the Netherlands. Pieter GM van der Valk, Dick A Groeneweg*, Rudolf HJ Evers**, Caroline van Voorst. University Hospital Nijmegen, *Maasziekhuis Bowmeer, **HELPmedical Laren, The Netherlands. Poster presented at Dermatology Congress, Wilderness, South Africa 1999..

5) Tzaneva S, Höningsman H, Tanew S. Observer-blind, randomised, intra patient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis.; British Journal of Dermatology 2003; Aug;149(2):350-3

6) Comparison of calcipotriene [Dovonex] with coal tar [Exorex] in treating psoriasis in adults: a pilot study. Arch. Dermatol(1999) 135:474-5. Veronikis I E, Malbanan A O, Holick M F.